glp-1 obesity drug supply news today How and Demand for Weight Loss Drugs is Playing Out in 2026 The expanding benefits of GLP-1
Description
Life Sciences 2 min read Dr Reddys launches generic semaglutide in India at 4,200 per month The once-weekly injection, approved by the DCGI, marks the companys entry into GLP-1 therapies as patent expiry opens the market to competition
It has been licensed worldwide for the treatment of type 2 diabetes mellitus in adult patients, including in the United States and Europe
They tested thousands of different combinations of linkers, fatty acids along with changes the amino acid sequence leading to the development of semaglutide, an ultrastable receptor agonist in which a carboxylated fatty acid is coupled to lysine 26 via a hydrophilic linker (Fig
Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated With GLP-1 Receptor Agonists: A Multidisciplinary Expert Consensus
SOURCE: U.S
A December 2025 study suggested that Trulicity may not impact a babys viability or affect the moms pregnancy hormones
